Fresenius SE & Co KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius SE & Co KGaA with three other
health care providers in Europe:
sales of 3.14 billion Euro [US$3.55 billion]
Ramsay Generale De Sante SA
(2.23 billion Euro [US$2.52 billion]
of which 82%
was Hospitals/Surgery), and
Fresenius Medical Care AG & Co. KGaA
(17.78 billion Euro [US$20.09 billion]
of which 72%
was North America).
During the year ended December of 2017, sales at
Fresenius SE & Co KGaA were 33.89 billion Euro (US$38.29 billion).
increase of 15.0%
versus 2016, when the company's sales were 29.47 billion Euro.
This was the fifth consecutive year of sales increases at Fresenius SE & Co KGaA
(and since 2012, sales have increased a total of 74%).
Sales of Fresenius Helios saw an increase
that was more than double the company's growth rate: sales were up
48.1% in 2017, from
5.84 billion Euro to 8.65 billion Euro.
Fresenius SE & Co KGaA also saw significant increases in sales in
Corporate/other (up 25.0% to 5.00 million Euro)